NF-κB-Related Metabolic Gene Signature Predicts the Prognosis and Immunotherapy Response in Gastric Cancer

Figure 9

Performance assessment of the RS for survival predication in training and validation set. (a, b) Survival analysis of the RS in (a) TCGA and (b) GSE62254 datasets showed that the low-risk group had a longer OS than the high-risk group. (c, d) RS was calculated in (c) TCGA and (d) GSE62254 datasets and displayed as scatter diagram. (e, f) The expression of the related NFMGs in (e) TCGA and (f) GSE62254 datasets. (g, h) DCA analysis was used to evaluate the efficacy of the RS in (g) TCGA and (h) GSE62254 datasets. RS: risk score; TCGA: The Cancer Genome Atlas; OS: overall survival; NFMGs: NF-κB-targeted metabolic genes; DCA: decision curve analysis.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)